Literature DB >> 29977253

Prevalence and risk factors for brucellosis in prolonged fever patients in post-conflict Northern Uganda.

Harriet N Muloki1,2, Joseph Erume2, David O Owiny2, Joseph M Kungu3, Jesca Nakavuma2, Duncan Ogeng1, George W Nasinyama2.   

Abstract

BACKGROUND: Brucellosis is a disease with significant public and economic implications but strategies for controlling this disease remain problematic.
OBJECTIVES: This study sought to determine the sero-prevalence of brucellosis in prolonged fever patients and to identify modifiable risk factors for the infection in humans in post conflict Northern Uganda.
METHODS: The study employed a cross-sectional method among prolonged fever patients who had visited selected health facilities in the study districts in Northern Uganda. Sero-prevalence of brucellosis was calculated for i-ELISA IgG/IgM. A structured questionnaire was used to obtain data on possible risk factors for brucellosis. Associations between sero-prevalence and risk factors were measured using the Odds Ratio.
RESULTS: Brucellosis was confirmed in 18.7% of the 251 patients that tested positive for the disease, with the rapid Brucella Plate Agglutination Test, and ages 10-84 years (median age 47+0.86). Sex (p = 0.001; OR 3.79; 95% CI 1.75 - 8.24), rearing livestock (p < 0.005; OR 8.44; 95% CI 2.84-25.03) and consumption of unpasteurised milk (p = 0.023; OR 2.57; 95% CI 1.14-5.80) were factors associated with brucellosis.
CONCLUSION: Control of brucellosis in animals, training and sensitisation of the community on brucellosis is needed to stimulate action on human brucellosis control.

Entities:  

Keywords:  Brucellosis; Uganda; fever; human; prevalence; zoonosis

Mesh:

Substances:

Year:  2018        PMID: 29977253      PMCID: PMC6016978          DOI: 10.4314/ahs.v18i1.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


Introduction

Brucellosis is a widespread zoonosis of both public health and economic concern1–3. The global burden of human brucellosis remains enormous with more than 500,000 new infections occurring annually worldwide4. Brucellosis is caused by organisms of genus Brucella with six pathogenic species of which four are known to cause human disease5. B. melitensis cause the most severe human disease, followed by B. suis, B. abortus and B. canis6. In humans brucellosis is transmitted by direct or indirect contact with infected animals and their products7. Inhalation of infectious aerosols and ingestion of raw milk or unpasteurized dairy products or meat from an infected animal is the most frequent route of infection8,9. Major symptoms for brucellosis in humans include; undulant fever, weight loss, back pain, fatigue and night sweats1. Diagnosis of brucellosis is impossible without laboratory confirmation involving a combination of methods10. Blood culture for Brucellae isolation remains the gold standard11 but may not provide a positive result for all patients12. Nucleic acid amplification can provide rapid detection and confirmation of Brucella13 but standardization of extraction methods, infrastructure, equipment and expertise are still lacking6. Bacteriological and genomic limitations make serology the most practical and useful tool for brucellosis diagnosis11. The serological tests like Rose Bengal Plate Agglutination Test (RBPT), standard tube agglutination test (STAT), Enzyme Linked Immuno-Sorbent Assay (ELISA) and fluorescence polarization assay (FPA) among others have been applied in human brucellosis diagnosis11,13,14. However, STAT remains the most popular serological test used14 and titres of 1:160 and above are considered diagnostic13. Nevertheless, STAT has limitations making ELISA to be most acceptable for diagnosing human brucellosis11,15,16. Mantur and others11 found ELISA to be more sensitive than STAT in detecting brucellosis in both acute and chronic cases while sensitivity and specificity of ELISA was reported to be 71.3% and 100% respectively. Araj and others15 reported sensitivities of 100% and 91% for IgM and IgG ELISAs, respectively, and a specificity of 100% for both assays. In addition, Asaad and other workers16 reported sensitivities of ELISA IgM and IgG to be 85.2% and 96.3%,respectively and specificity of 100% for each.. Human brucellosis occurs widely in Uganda8,17,18. A recent study carried out in Gulu district in Northern Uganda reported individual animal and herd level sero-prevalence of bovine brucellosis to be 6% and 19%, respectively. Restocking and communal grazing were the major risk factors associated with the disease19. Northern Uganda is under rehabilitation with promotion of livestock rearing and re-stocking. To date, no study has described human brucellosis in post conflict Northern Uganda, a region that witnessed a total breakdown in socio-economic infrastructure, governance and services. The aim of this study was to estimate the sero-prevalence of human brucellosis in prolonged fever patients and identify modifiable risk factors for the infection in post-conflict Northern Uganda. This study considered ELISA IgG/IgM which is reported as the most specific serology test against SAT.

Methods

Ethics and consent to participate statement

Ethical approval was obtained from Gulu University Research Council (Ref No: GU/IRC/02/07/13) and the Uganda National Council of Science and Technology (UNCST) Reference No: HS 1442. Written consent/assent was sought from all individuals before enrolment. The study was carried out in post-conflict areas of Northern Uganda, in the districts of Apac, Gulu, Lira and Pader covering up to nine percent of the country's 236,040 Km2 area size.

Study design and enrolment of study patients

A cross-sectional study was conducted from March 2014 to February 2015. Study patients were selected from 17 out of the 244 public and private health facilities in the study area20–23. The health facilities were purposively selected basing on capacity to test for brucellosis and willingness to participate in the study. The study targeted patients with fever, headache, joint pain, malaise, backache, fatigue and loss of appetite visiting study health facilities. Medical personnel in the out patient department (OPD) identified suspects and tested them with the rapid Brucella Plate Agglutination Test (BPAT). The sample size for study subjects was calculated using the formula for cross sectional survey as described before24 at 5% desired precision and 95% confidence interval with prevalence of human brucellosis in Uganda estimated at 18%8.

Laboratory investigation

To determine the sero-prevalence of brucellosis in prolonged fever patients, STAT 1: 160 was used as the standard serological test against SAT 1: 320, iELISA IgG, iELISA IgM and iELISA IgG/IgM. Only BPAT positive samples from consented subjects were further investigated. All subjects were briefed on the objectives of the study, and signed a consent form. Cephalic vein blood was collected into sterile silicon-coated tubes without anticoagulant for serum harvesting after 24 hours at room temperature. The serum was transported on ice to Makerere University, College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) and kept at -20°C. Samples were analysed using STAT (Remel kit, Europe) and i-ELISA (Vircell S.L, Santa Fe, and Granada, Spain) according to the manufacturers' guidelines. To improve sensitivity, results for i-ELISA, were interpreted in parallel, with any IgG or IgM positive test reported as positive for i-ELISA as described previously17. A structured questionnaire was used to obtain data on possible risk factors for human brucellosis. Information collected from study subjects included age, gender, district of origin, education level, rearing livestock, knowledge on brucellosis transmission and practice of consumption of unpasteurized milk/milk products.

Statistical analysis

Sero-prevalence of brucellosis in humans was calculated for both STAT and i-ELISA (IgG and IgM). Associations between sero-prevalence of human brucellosis and modifiable risk factors were assessed with a Chi-square test and Odds Ratio at 95% confidence interval using SPSS, (SPSS Inc. Chicago, USA Version 16.0). Variables with p ≤ 0.1 at univariable analysis were included in a multivariable logistic regression model. The backward selection procedure was used to identify factors for the final models. Goodness of fit for the final model was assessed using Hosmer and Lemeshow goodness of fit test.

Results

A total of 251 prolonged fever patients aged 10–84 years (median age 47.0± 0.86) were enrolled in the study (Fig 1).
Figure 1

Distribution of study patients by gender and age group

Distribution of study patients by gender and age group Up to 207 study subjects were from government and 44 from private health facilities. All serological tests showed significant (p<0.05) differences in brucellosis sero-positivity between health facilities, sex and keeping livestock. In addition brucellosis sero-positivity differed significantly (p<0.05) with consumption of milk and milk products basing on STAT 1:160, 1:320 and i-ELISA IgM, but did not differ basing on i-ELISA IgG. There was no difference in sero-positivity with education level (p>0.05) basing on all the four serological tests (Table 1).
Table 1

Sero-prevalence of brucella among prolonged fever patients

Test Results (%,p-value), n=251
VariableCategoryFrequencySTAT 1:160STAT1:320i-ELISA IgGi-ELISA IgM
Health facilityGovernment20732.7(0.000)*17.5(0.026)*12.7(0.005)*10.8(0.039)*
Private442.01.20.00.4
GenderMale11719.9(0.012)*11.2 (0.048)*10.8(0.000)*8.4(0.001)*
Female13414.77.51.92.8
Age category of patientsChildren80.8(0.887)0.0(0.0507)0.0(0.722)0.0(0.361)
Youth18826.314.39.67.6
Adult416.03.62.42.4
Elderly141.60.80.81.2
Educational≤Primary15222.7(0.242)11.2(0.878)7.6(0.883)8.0(0.212)
level> Primary9912.07.55.13.2
Keep livestockYes14529.9(0.000)*16.3(0.000)*11.1(0.000)*10.4(0.000)*
No1064.82.41.60.8
Knowledge TransmissionNo23131.5(0.601)16.7(0.453)11.6(0.753)9.2(0.040)*
Yes203.22.01.12.0
Consume pasteurised Milk/milk productsNo15127.1(0.000)*17.1(0.000)*9.6(0.066)9.2(0.012)*
Yes1007.61.63.12.0

5% level of significance

Sero-prevalence of brucella among prolonged fever patients 5% level of significance Basing on the parallel interpretation of either positive i-ELISA IgG or IgM or both tests, brucellosis sero-prevalence differed significantly (p<0.05) with gender, rearing livestock and consumption of unpasteurised milk/milk products (Table 2).
Table 2

Relationship between the hypothesised risk factors for human brucellosis and sero-positivity based on i-ELISA IgG/IgM.

VariableCategory% test positive (n=251)χ2dfp-value
GenderMale14.320.891<0.005*
Female4.4
Age group< 30years5.23.1510.076
> 30 years13.5
Education level≤Primary12.00.2610.611
> Primary6.7
Keep livestockYes17.126.951<0.005*
No1.6
Knowledge onNot Know14.31.8210.178
TransmissionKnowledgeable3.4
Consume milkUnpasteurised14.78.3210.004*
and milk productsPasteurised4.0

Significant at 5% level

Relationship between the hypothesised risk factors for human brucellosis and sero-positivity based on i-ELISA IgG/IgM. Significant at 5% level Gender (OR 3.79; 95% CI: 1.75–8.24), livestock rearing (OR 8.44; 95% CI: 2.84–25.03) and consumption of unpasteurised milk (OR 2.57; 95% CI: 1.14–5.80) were significantly associated with brucellosis. The model explained 30.9% (NagelkerkeoR2) of the variance in brucellosis sero-prevalence and correctly classified 83.3% of the cases. The Odds of being brucella positive in males with prolonged fever were four times the Odds in females. Livestock rearing was highly associated with brucella sero-positivity and consumption of unpasteurised milk and milk products increased the likelihood of testing brucella sero-positive (Table 3).
Table 3

Multivariable logistic regression of factors associated with human brucellosis in post-conflict northern Uganda

VariableCategory% Sero- positivity (n=251)Odds Ratios(95%CI)p-values
GenderMale14.33.79(1.75–8.24)0.001*
Female4.4
Age group< 30 years5.21.73 (0.80–3.75)0.164
> 30 years13.5
Keep livestockYes17.18.44(2.84–25.03)0.005*
No1.6
Consumption ofUnpasteurised14.72.57(1.14–5.80)0.023*
Milk/milk productsPasteurised4.0

5% level of significance

Multivariable logistic regression of factors associated with human brucellosis in post-conflict northern Uganda 5% level of significance

Discussion

This is the first study to document the sero-prevalence of human brucellosis among patients with prolonged fever in Northern Uganda. The study showed sero-prevalence of human brucellosis in Northern Uganda to be 18.7% with i- ELISA and 34.7% with STAT (1:160). However, sero-positivity with STAT titres (1>1:320) was 18.7%, an indication of active infection. This is not surprising since study subjects had come to seek medical attention with symptoms relating to brucellosis. This finding is comparable to a recent study17 which reported STAT sero-prevalence results not to be different (p<0.05) from that for c-ELISA. Findings here support the use of ELISA tests for confirming brucellosis in low-income countries where brucellosis is endemic. This study showed men to be four times likely to test positive for brucellosis than women. In the current study, milking and grazing animals is a man's role thus men are more in contact with animals than women. This finding is supported by reports of epidemiological studies in other parts of the world where human brucellosis is considered an occupational disease25. In addition, reports show no sex-wise discrimination of brucellosis infection between male and female as both have equal susceptibility if provided with exposure to potential risk factors26. Nevertheless, the current study contradicts studies elsewhere which reported high prevalence of brucellosis among females than males25,27. This study clearly shows livestock rearing (p<0.005) to be strongly associated with human brucellosis. Generally, livestock harbour brucellosis in a sub-clinical state and farm families are at high risk of exposure to the disease through contact with fluids of affected livestock or consumption of their unpasteurized products. This study is in agreement with Corbel6 who pointed out that when animals are kept in close proximity to human habitat, the practice can result in brucella infection as people are in constant contact with infective materials. This study has also shown brucellosis sero-positivity to be highly associated with consumption of unpasteurised milk/milk products. This finding parallels another study28 which reported that significantly (p<0.02) more sero-positive humans with a history of raw milk. This calls for increased awareness among the communities in post-conflict Northern Uganda about the dangers associated with drinking raw milk, among others. Since this study dealt with only suspected brucellosis patients and did not cover all health facilities, results need to be interpreted cautiously. However, the study has provided important information to support brucellosis control programs.

Conclusion and recommendations

Findings in this study show clearly that the sero-prevalence of human brucellosis among patients with prolonged fever is high (18.7%). Rearing livestock and consumption of unpasteurised milk/milk products were factors associated with brucellosis. Strategies to control animal brucellosis and raising awareness about the consumption of unpasteurised milk and milk products are necessary to reduce the incidence of human infection in Northern Uganda. Innovative methods to sensitize the community on brucellosis and cost effective methods to control animal brucellosis are recommended.
  19 in total

1.  Brucella sero-prevalence and modifiable risk factors among predisposed cattle keepers and consumers of un-pasteurized milk in Mbarara and Kampala districts, Uganda.

Authors:  George Nasinyama; Edward Ssekawojwa; John Opuda; Patrice Grimaud; Eric Etter; Alban Bellinguez
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis.

Authors:  George F Araj; Mireille M Kattar; Layla G Fattouh; Kayane O Bajakian; Sara A Kobeissi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

Review 3.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

4.  Specificity of a polymerase chain reaction assay of a target sequence on the 31-kilodalton Brucella antigen DNA used to diagnose human brucellosis.

Authors:  M C Casañas; M I Queipo-Ortuño; A Rodriguez-Torres; A Orduña; J D Colmenero; P Morata
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

Review 5.  Human brucellosis.

Authors:  John M Sauret; Natalia Vilissova
Journal:  J Am Board Fam Pract       Date:  2002 Sep-Oct

6.  Selected laboratory tests in febrile patients in Kampala, Uganda.

Authors:  L N Mutanda
Journal:  East Afr Med J       Date:  1998-02

Review 7.  Review of clinical and laboratory features of human brucellosis.

Authors:  B G Mantur; S K Amarnath; R S Shinde
Journal:  Indian J Med Microbiol       Date:  2007-07       Impact factor: 0.985

8.  Prevalence of and factors associated with Brucella sero-positivity in cattle in urban and peri-urban Gulu and Soroti towns of Uganda.

Authors:  Denis Rwabiita Mugizi; Sofia Boqvist; George William Nasinyama; Charles Waiswa; Kokas Ikwap; Kim Rock; Elisabeth Lindahl; Ulf Magnusson; Joseph Erume
Journal:  J Vet Med Sci       Date:  2015-02-14       Impact factor: 1.267

9.  Survey of Brucella infection and malaria among Abattoir workers in Kampala and Mbarara Districts, Uganda.

Authors:  Immaculate Nabukenya; Deogratius Kaddu-Mulindwa; George William Nasinyama
Journal:  BMC Public Health       Date:  2013-09-30       Impact factor: 3.295

10.  Sample size calculation in medical studies.

Authors:  Mohamad Amin Pourhoseingholi; Mohsen Vahedi; Mitra Rahimzadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more
  3 in total

1.  Serological detection of brucellosis among febrile, malaria-negative children and domesticated dogs in an urban African setting.

Authors:  John B Kalule; Joseph Tomusange; Teddy Namatovu
Journal:  Afr J Lab Med       Date:  2020-09-30

2.  Molecular epidemiology of Brucella species in mixed livestock-human ecosystems in Kenya.

Authors:  James M Akoko; Roger Pelle; AbdulHamid S Lukambagire; Eunice M Machuka; Daniel Nthiwa; Coletha Mathew; Eric M Fèvre; Bernard Bett; Elizabeth A J Cook; Doreen Othero; Bassirou Bonfoh; Rudovick R Kazwala; Gabriel Shirima; Esther Schelling; Jo E B Halliday; Collins Ouma
Journal:  Sci Rep       Date:  2021-04-23       Impact factor: 4.379

3.  Serosurvey and Risk Factors Associated with Brucella Infection in High Risk Occupations from District Lahore and Kasur of Punjab, Pakistan.

Authors:  Shahzad Ali; Usama Saeed; Muhammad Rizwan; Laiba Hassan; Muhammad Ali Syed; Falk Melzer; Hosny El-Adawy; Heinrich Neubauer
Journal:  Pathogens       Date:  2021-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.